Vertex Pharmaceuticals, Inc. (VRTX)
541.69
-5.86
(-1.07%)
USD |
NASDAQ |
Aug 28, 16:00
541.81
+0.12
(+0.02%)
After-Hours: 20:00
Vertex Pharmaceuticals Research and Development Expense (Annual) : 3.754B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.754B |
| December 31, 2024 | 3.630B |
| December 31, 2023 | 3.163B |
| December 31, 2022 | 2.643B |
| December 31, 2021 | 3.051B |
| December 31, 2020 | 1.830B |
| December 31, 2019 | 1.755B |
| December 31, 2018 | 1.416B |
| December 31, 2017 | 1.325B |
| December 31, 2016 | 1.048B |
| December 31, 2015 | 995.92M |
| December 31, 2014 | 855.51M |
| December 31, 2013 | 918.78M |
| December 31, 2012 | 806.18M |
| December 31, 2011 | 707.71M |
| December 31, 2010 | 637.42M |
| December 31, 2009 | 550.27M |
| December 31, 2008 | 516.29M |
| Date | Value |
|---|---|
| December 31, 2007 | 513.05M |
| December 31, 2006 | 371.71M |
| December 31, 2005 | 248.54M |
| December 31, 2004 | 192.16M |
| December 31, 2003 | 199.64M |
| December 31, 2002 | 203.02M |
| December 31, 2001 | 148.67M |
| December 31, 2000 | 84.92M |
| December 31, 1999 | 72.18M |
| December 31, 1998 | 58.67M |
| December 31, 1997 | 51.62M |
| December 31, 1996 | 32.05M |
| December 31, 1995 | 37.80M |
| December 31, 1994 | 31.28M |
| December 31, 1993 | 19.27M |
| December 31, 1992 | 8.731M |
| December 31, 1991 | 5.851M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Sionna Therapeutics, Inc. | 60.26M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Biogen, Inc. | 1.481B |